Fairvalue-Calculator Fairvalue-Calculator
EN DE

Unibios Holdings (BIOSK) Fair Value & Analysis

Industrials · GR · Market cap €42.7M

Price€2.45
Fair Value€1.59
Upside-35.0%
Quality85/100
Evidence: Medium Range €1.19 – €1.99

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Unibios Holdings (BIOSK) currently trades at €2.45, while our model-based Fair Value estimate is €1.59 — implying the stock looks roughly 35.0% overvalued today. We read business quality at 85/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment and recycling systems in Europe, Africa, and the Middle East. It provides installation and rental of faced scaffolding; and maintains and installs heating and air conditioning equipment. The company was formerly known as Biossol SA and changed its name to Unibios Holdings S.A. in July 2008. Unibios Holdings S.A. was incorporated in 1940 and is based in Ano Liosia, Greece.

Open the full interactive analysis →

Similar stocks

Veralto Corporation (VLTO) -16% Canmax Technologies Co (300390) -88% Zurn Elkay Water Solutions Corporation (ZWS) -51% Kurita Water Industries Ltd (KTWIY) -65% Munters Group (MTRS) -72% Fujian Longking Co (600388) +2%

Frequently asked questions

Is Unibios Holdings (BIOSK) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €1.59 versus a price of €2.45 — about −35% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BIOSK?
Our 21-model fair value for Unibios Holdings is €1.59 (as of Jun 24, 2026), built from audited fundamentals. The current price is €2.45.
What is the quality score of BIOSK?
Unibios Holdings has a Quality Score of 85/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.